首页> 外文会议>International Symposium on Medical and Pharmaceutical Biotechnology(医药生物技术国际研讨会) >Antigenic epitope analysis, expression and purification of extracellular region fragment of herpes simplex virus type I glycoprotein B in eukaryotic cell
【24h】

Antigenic epitope analysis, expression and purification of extracellular region fragment of herpes simplex virus type I glycoprotein B in eukaryotic cell

机译:真核细胞I型单纯疱疹病毒糖蛋白B的抗原表位分析,表达及纯化

获取原文
获取原文并翻译 | 示例

摘要

In order to prevent infection from herpes simplex virus type I (HSV-1), and make the found for the construction of subunit vaccine, a truncated (extracellular region gene fragment) HSV-1 gB gene was cloned and expressed in eucaryotic cells by genetic engineering technology. After analizing the amino acid sequences of gB1 protein using Anthewin software, its antigenic epitopes were screened. Then the eucaryotic expression vector pCEP4 was constructed that contained the chemosynthetic selected sequence encoding HSV-1 gB with optimized signal peptide. Subsequently, transfecting the recombiant plasmid into HEK 293 cells and selecting it with hygromycin B, gB1 recombinant protein was then expressed in culture medium and purified through Ni affinity chromatography. The recombinant eukaryotic plasmid pCEP4-gB1 was constructed successfully, which was confirmed by the following SDS-PAGE and Western blot analysis. One major protein band (approximate molecular weights of 75 kDa) was observed, while no corresponding band was detected in uninduced extract. ELISA detection indicated that expressed gB1 had good antigenicity. The construction of truncated HSV-1 subunit vaccine is identified; it is powerful to induce immunoreactions and is promising for the treatment of HSV-1.
机译:为了预防I型单纯疱疹病毒(HSV-1)的感染并发现亚单位疫苗的构建,克隆了截短的(细胞外区域基因片段)HSV-1 gB基因,并通过遗传在真核细胞中表达工程技术。使用Anthewin软件分析gB1蛋白的氨基酸序列后,筛选其抗原表位。然后构建真核表达载体pCEP4,其包含编码具有优化信号肽的HSV-1 gB的化学合成选择序列。随后,将重组质粒转染到HEK 293细胞中,并用潮霉素B进行筛选,然后在培养基中表达gB1重组蛋白,并通过Ni亲和层析纯化。成功构建了重组真核质粒pCEP4-gB1,通过以下SDS-PAGE和Western印迹分析证实了这一点。观察到一个主要的蛋白条带(分子量约为75 kDa),而未诱导的提取物中未检测到相应的条带。 ELISA检测表明表达的gB1具有良好的抗原性。确定了截短的HSV-1亚单位疫苗的构建;它具有强大的免疫反应能力,有望用于HSV-1的治疗。

著录项

  • 来源
  • 会议地点 Nanjing(CN)
  • 作者单位

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China;

    The East-China Institute for Medical Biotechnics, Nanjing, 210002, China;

    Department of Biochemistry and Molecular Biology, School of Preclinical Medicine, Nanjing Medical University, Nanjing, 210029, China The East-China Institute for Medical Biotechnics, Nanjing, 210002, China;

  • 会议组织
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    herpes simplex virus I; gB1 protein; subunit vaccine; antigenicity;

    机译:单纯疱疹病毒I; gB1蛋白;亚单位疫苗;抗原性;
  • 入库时间 2022-08-26 14:06:01

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号